207 related articles for article (PubMed ID: 15699110)
1. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells.
MacDonald KP; Rowe V; Clouston AD; Welply JK; Kuns RD; Ferrara JL; Thomas R; Hill GR
J Immunol; 2005 Feb; 174(4):1841-50. PubMed ID: 15699110
[TBL] [Abstract][Full Text] [Related]
2. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
4. Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation.
Li JM; Southerland LT; Lu Y; Darlak KA; Giver CR; McMillin DW; Harris WA; Jaye DL; Waller EK
J Immunol; 2009 Dec; 183(12):7799-809. PubMed ID: 19933853
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells.
Banovic T; Markey KA; Kuns RD; Olver SD; Raffelt NC; Don AL; Degli-Esposti MA; Engwerda CR; MacDonald KP; Hill GR
J Immunol; 2009 Jan; 182(2):912-20. PubMed ID: 19124734
[TBL] [Abstract][Full Text] [Related]
6. G-CSF-Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way.
Perobelli SM; Mercadante AC; Galvani RG; Gonçalves-Silva T; Alves AP; Pereira-Neves A; Benchimol M; Nóbrega A; Bonomo A
J Immunol; 2016 Nov; 197(9):3725-3734. PubMed ID: 27707998
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
8. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
Morris ES; MacDonald KP; Hill GR
Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
Pan L; Delmonte J; Jalonen CK; Ferrara JL
Blood; 1995 Dec; 86(12):4422-9. PubMed ID: 8541530
[TBL] [Abstract][Full Text] [Related]
10. Donor APCs are required for maximal GVHD but not for GVL.
Matte CC; Liu J; Cormier J; Anderson BE; Athanasiadis I; Jain D; McNiff J; Shlomchik WD
Nat Med; 2004 Sep; 10(9):987-92. PubMed ID: 15286785
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
Capitini CM; Davis JP; Larabee SM; Herby S; Nasholm NM; Fry TJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):790-9. PubMed ID: 21216299
[TBL] [Abstract][Full Text] [Related]
12. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P
J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
16. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
[TBL] [Abstract][Full Text] [Related]
17. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
18. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF is an essential regulator of T cell activation competence in uterine dendritic cells during early pregnancy in mice.
Moldenhauer LM; Keenihan SN; Hayball JD; Robertson SA
J Immunol; 2010 Dec; 185(11):7085-96. PubMed ID: 20974989
[TBL] [Abstract][Full Text] [Related]
20. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
